Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.

Journal Article

Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) is a multicenter, randomized, double blind, placebo-controlled trial that is being conducted under the auspices of the Muscle Study Group. EPITOME is the first randomized control trial in patients with ocular myasthenia and aims to evaluate the efficacy and tolerability of prednisone over a period of four months in patients with newly diagnosed ocular myasthenia whose symptoms have failed to remit in response to a trial of cholinesterase inhibitor therapy.

Full Text

Duke Authors

Cited Authors

  • Benatar, M; Sanders, DB; Wolfe, GI; McDermott, MP; Tawil, R

Published Date

  • December 2012

Published In

Volume / Issue

  • 1275 /

Start / End Page

  • 17 - 22

PubMed ID

  • 23278573

Electronic International Standard Serial Number (EISSN)

  • 1749-6632

Digital Object Identifier (DOI)

  • 10.1111/j.1749-6632.2012.06780.x

Language

  • eng

Conference Location

  • United States